ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nichi-Iko Pharmaceutical Co., Ltd.
  3. Financials
  4. Gross profit

Nichi-Iko Pharmaceutical Co., Ltd. (E00963)

Market cap
P/E ratio
Nichi Iko manufactures and sells generic drugs to hospitals, clinics, and pharmacies through pharmaceutical wholesalers, serving 136,000 medical institutions.
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 20223,965-81.34%
Mar 31, 202121,245-43.07%
Mar 31, 202037,319+12.55%
Mar 31, 201933,157-18.74%
Mar 31, 201840,803-28.08%
Mar 31, 201756,735+6.02%
Mar 31, 201653,514+13.65%
Mar 31, 201547,086

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat